Endocrinology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Thyroid. 2011 Aug;21(8):845-53. doi: 10.1089/thy.2011.0011.
High-resolution ultrasound (US) is the primary tool used to identify locoregional recurrences in differentiated thyroid cancer. Although small thyroid bed (TB) nodules are a commonly reported sonographic finding, their natural history, regardless of whether they are benign or malignant, has not been well characterized. This study was designed to determine the likelihood, magnitude, and rate of growth of small TB nodules identified on routine surveillance neck US after thyroidectomy for differentiated thyroid cancer as well as to identify ultrasonographic and clinical predictors of growth.
This retrospective review identified 191 patients with at least one TB nodule (≤ 11 mm) on the first postoperative US performed at a comprehensive cancer center. Change in size of each TB nodule was determined using serial US studies over time. Clinicopathologic and sonographic characteristics were analyzed as possible predictors for growth of the TB nodules.
Over a median clinical follow-up of 5 years, 9% (17/191) of patients had increase in size of at least one TB nodule. Median size of the TB nodules was 5 mm (range: 2-11 mm). Suspicious US features were seen in 63% (121/191) of patients with TB nodules identified on initial US and in 31% (21/67) of those with TB nodules detected on subsequent follow-up US. The rate of growth was 1.3 mm/year in those nodules showing an increase in size and thus demonstrated a significant increase in size only after several years of follow-up. The negative predictive values associated with the absence of any suspicious US features (0.97), the absence of abnormal cervical lymph nodes (0.94), and the lack of a rising serum thyroglobulin (0.93) provided clinically useful information regarding the likelihood that nodules would not increase in size.
Most TB nodules do not show clinically significant growth over several years of follow-up. Thus, TB nodules can be followed up with cautious observation and serial ultrasonography using an approach similar to that recommended by the American Thyroid Association thyroid cancer guidelines for the management of small abnormal cervical lymph nodes.
高分辨率超声(US)是识别分化型甲状腺癌局部复发的主要工具。尽管甲状腺床(TB)小结节是一种常见的超声表现,但无论其良恶性,其自然史尚未得到很好的描述。本研究旨在确定分化型甲状腺癌术后常规颈部超声监测中发现的 TB 小结节的可能性、大小和生长速度,并确定生长的超声和临床预测因素。
本回顾性研究共纳入 191 例在综合癌症中心进行的首次术后 US 检查中至少有一个 TB 结节(≤11mm)的患者。通过随时间进行的系列 US 研究确定每个 TB 结节的大小变化。分析临床病理和超声特征是否为 TB 结节生长的预测因素。
在中位数为 5 年的临床随访中,9%(17/191)的患者至少有一个 TB 结节的大小增加。TB 结节的中位数大小为 5mm(范围:2-11mm)。在初始 US 中发现的 TB 结节中有 63%(121/191)患者和在后续随访 US 中发现的 TB 结节中有 31%(21/67)患者存在可疑的 US 特征。大小增加的 TB 结节的生长速度为 1.3mm/年,且仅在数年随访后才表现出明显的增大。无任何可疑 US 特征(0.97)、无异常颈部淋巴结(0.94)和血清甲状腺球蛋白升高(0.93)的阴性预测值为评估结节是否增大提供了有用的临床信息。
大多数 TB 结节在数年的随访中不会出现临床显著的生长。因此,TB 结节可以通过谨慎观察和使用类似于美国甲状腺协会甲状腺癌指南推荐的方法进行随访,以管理小的异常颈部淋巴结。